P81
Med. Mal. Infect., 2009,
Contribution de la biologie moléculaire et de l'antigénémie galactomannane aspergillaire au diagnostic de l'histoplasmose.
doi:10.1016/j.medmal.2009.10.005, sous presse.
P80
PLoS ONE, 2009, 4(10), 1-9.
Infectivity of Leishmania mexicana Is Associated with Differential Expression of Protein Kinase C-Like Triggered during a Cell-Cell.
P79
Bioorg. Med. Chem. Lett., 2009, 19(20), 5833-5836.
Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
P78
J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.
A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.
P77
J. Enz. Inh. Med. Chem., 2009, 24(5), 1067-1075.
Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl)indoles as antileishmanial agents. Part II.
P76
Bioorg. Med. Chem., 2009, 17(18), 6715-6727.
Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
P75
Tetrahedron Lett., 2009, 50(41), 5729-5732.
A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination.
P74
Bioorg. Med. Chem. Lett., 2009, 19(2), 301-304
Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.